Therefore, understanding the expression of TMPRSS2 in tumor patients and its relationship with prognosis is helpful to elucidate the reasons why tumor patients are more prone to COVID‐19 infection, and to determine whether tumor immunotherapy affects their susceptibility. The gene discussed is TMPRSS2; the disease is neoplasm.